[1]
N. Wongsurawat, C. Somboonporn, Y. Raruenrom, and B. Thinkhamrop, “Low versus high 131I therapeutic effectiveness for differentiated thyroid cancer with intermediate risk of recurrence”, Asia Pac J Sci Technol, vol. 27, no. 04, pp. APST–27, May 2022.